Pimasertib, also known as AS703026, SAR245509, MSC1936369B, is a n orally bioavailable small-molecule inhibitor of MEK1 and MEK2 (MEK1/2) with potential antineoplastic activity. MEK inhibitor AS703026 selectively binds to and inhibits the activity of MEK1/2, preventing the activation of MEK1/2-dependent effector proteins and transcription factors, which may result in the inhibition of growth factor-mediated cell signaling and tumor cell proliferation.
相关文献及参考
Billadeau, D., et al.: Cancer Res., 55, 3640 (1995),
Kolch, W., et al.: Biochem. J., 351, 289 (2000),
Smith, M., et al.: Leukemia, 17, 274 (2003),
Adjei, A., et al.: J. Clin. Oncol., 26, 2139 (2008),
安全信息
Storage condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).